R. David Hoover - 30 Nov 2021 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Director
Signature: /s/ Catherine Powell, as Attorney-in-Fact for R. David Hoover
Issuer symbol: ELAN
Transactions as of: 30 Nov 2021
Net transactions value: +$315,127
Form type: 4
Filing time: 02 Dec 2021, 16:16:40 UTC
Previous filing: 17 Nov 2021
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Purchase	$293,794	+10,000	+11%	$29.38	105,000	30 Nov 2021	Revocable Trust	F1
transaction	ELAN	Common Stock	Award	$0	+7,307	+23%	$0.000000	39,267	30 Nov 2021	Direct	F2
holding	ELAN	Common Stock						15,920	30 Nov 2021	Suzanne A. Hoover Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Deferred Stock Units	Award	$21,333	+742	+4.1%	$28.74	18,859	30 Nov 2021	Common Stock	742		Direct	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 30, 2021 with purchase prices ranging from $29.3587 to $29.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2	Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
F3	Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
F4	The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
F5	The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

Remarks:

Chairman of the Elanco Board of Directors